Skip to content

Solid Biosciences

US · SLDB #3476 by market cap Listed 2018
6.85 -0.07 -1.01%
Live - 5344 symbols - heartbeat 92s ago · 2026-10-08 09:04
Pre-market 6.73 -1.75%
After-hours 6.85 0.00%
Overnight 6.87 +0.29%
Market cap
734.49M
P/B
1.96
EPS
-1.99
Reader sentiment Are you bullish or bearish on SLDB?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 10 analysts

Buy
Avg price target 19.00 +177.4%
Price target rangecurrent 6.85
Low11.00
Avg19.00
High26.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-09-30 Piper Sandler -- BUY 18.00
2026-09-16 Leerink Partners -- BUY 20.00
2026-09-16 RBC Capital -- BUY 18.00
2026-09-15 Cantor Fitzgerald -- BUY 26.00
2026-09-14 H.C. Wainwright -- BUY 25.00
2026-09-10 Citi -- BUY 14.00
2026-08-26 Cantor Fitzgerald -- BUY 26.00
2026-08-21 Truist Financial -- BUY 20.00
2026-08-11 J.P. Morgan -- BUY 11.00
2026-08-10 H.C. Wainwright -- BUY 25.00
2026-08-07 Needham -- BUY 19.00
2026-08-07 Citi -- BUY 14.00
2026-08-06 William Blair -- BUY --
2026-07-01 H.C. Wainwright -- BUY 25.00
2026-06-04 Citi -- BUY 14.00
2026-06-03 H.C. Wainwright -- BUY 25.00
2026-05-22 J.P. Morgan -- BUY 11.00
2026-05-18 Wedbush -- BUY 16.00
2026-05-15 Wedbush -- BUY 16.00
2026-05-15 H.C. Wainwright -- BUY 20.00
2026-05-14 Needham -- BUY 19.00
2026-05-13 William Blair -- BUY --
2026-05-13 Piper Sandler -- BUY 18.00
2026-05-13 Wedbush -- BUY 16.00
2026-05-13 Needham -- BUY 19.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2022/Q1 2022-04-27 -- ±32.26% -16.98% (in line)
2021/Q1 2021-05-14 -- ±24.73% -21.40% (in line)
2020/Q3 2020-11-05 -- -- +0.00%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-08 09:04:36 · For reference only, not investment advice and not tailored to your situation.